Terms: = Kidney tumors AND TLX3, O43711, 30012, ENSG00000164438, HOX11L2, RNX
4 results:
1. Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature.
Nallandhighal S; Vince R; Karim R; Groves S; Stangl-Kremser J; Russell C; Hu K; Pham T; Cani AK; Liu CJ; Zaslavsky A; Mehra R; Cieslik M; Morgan TM; Palapattu GS; Udager AM; Salami SS
Eur Urol Oncol; 2022 Feb; 5(1):92-99. PubMed ID: 34840106
[TBL] [Abstract] [Full Text] [Related]
2. Outcomes for urologic oncology procedures: are there differences between academic and community hospitals?
Syed JS; Abello A; Nguyen J; Lee AJH; Desloges JJ; Leapman MS; Kenney PA
World J Urol; 2020 May; 38(5):1187-1193. PubMed ID: 31420696
[TBL] [Abstract] [Full Text] [Related]
3. Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial.
Gore ME; Griffin CL; Hancock B; Patel PM; Pyle L; Aitchison M; James N; Oliver RT; Mardiak J; Hussain T; Sylvester R; Parmar MK; Royston P; Mulders PF
Lancet; 2010 Feb; 375(9715):641-8. PubMed ID: 20153039
[TBL] [Abstract] [Full Text] [Related]
4. The prediction of renal function 6 years after unilateral nephrectomy using preoperative risk factors.
Ito K; Nakashima J; Hanawa Y; Oya M; Ohigashi T; Marumo K; Murai M
J Urol; 2004 Jan; 171(1):120-5. PubMed ID: 14665858
[TBL] [Abstract] [Full Text] [Related]
